RECURSION PHARMACEUTICALS, INC. ($RXRX)
Filing Information
| Accession Number | 0001601830-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,714,256
Total Value
$41,248.72
P&L
+inf% (+$5,537,649.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A Common Stock | โ | Feb 6, 2026 | Grant/Award | 1,673,546 | $0.00 | $0.00 | 2,284,681 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 6, 2026 | Grant/Award | 30,346 | $0.00 | $0.00 | 2,315,027 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Feb 6, 2026 | Tax Withholding | 10,364 | $3.98 | $41,248.72 | 2,304,663 | Direct | โ | View Details |